Enterovirus A71 neuroinvasion: central nervous system entry, blood–brain barrier dynamics, and multistage constraints
- 1Zunyi Medical University
- 2Zunyi Medical and Pharmaceutical College
Abstract
Enterovirus A71 (EV-A71) is an important cause of severe neurological complications of hand, foot, and mouth disease in children. Most infections remain confined to peripheral sites, whereas only a small proportion progress to central nervous system (CNS) disease, and the mechanisms underlying this transition remain incompletely understood. Here, we reappraise EV-A71 neuropathogenesis as a multistage process comprising peripheral replication, systemic dissemination, CNS entry, establishment of productive CNS infection, and subsequent tissue injury. This distinction is important because these events are mechanistically connected but not interchangeable. Current evidence supports both neurovascular and peripheral neural routes of CNS entry, although the nature and strength of the supporting evidence differ. Human-derived blood–brain barrier (BBB) models demonstrate that EV-A71 and virus-associated carriers can engage and cross neurovascular interfaces, whereas temporal studies in animals, perturbation of axonal transport, and compartmentalized neuronal models provide stronger causal support for retrograde axonal transport once the virus has accessed peripheral nerves. These findings establish mechanistic feasibility, but the timing, necessity, and relative contribution of each route during natural infection in children remain unresolved. We further emphasize that BBB crossing is not synonymous with BBB disruption, and that CNS entry does not necessarily result in productive CNS infection. On this basis, we propose a multistage progression-constraint model, in which progression to severe neurological disease requires EV-A71 to overcome distinct constraints imposed by tissue context, viral properties, and host factors at successive stages. This framework provides a testable explanation for why most infections remain peripheral while only a minority progress to severe neurological disease, and highlights the need for longitudinal clinical studies and directly comparable experimental models to identify where disease trajectories first diverge.
Related
- Clade-specific transmission dynamics of enterovirus D68 and their association with acute flaccid myelitis
- Cannabinoid modulation of central amygdala population dynamics during threat investigation
- Enterovirus 2B protein: From viroporin to membrane stress sensor, mechanistic principles of multi-pathway regulation.
- Beyond polio: advanced human in vitro models for studying non-polio enterovirus pathogenesis
- Invasive Enterovirus and Parechovirus Infections in Adults, Alberta, Canada, 2023–2025
BibTeX
@article{zhang2026enterovirus,
title = {{Enterovirus A71 neuroinvasion: central nervous system entry, blood–brain barrier dynamics, and multistage constraints}},
author = {Yi Zhang and Zhi Li and Yu Gu and Bo Huang and Zhenzhuang Zou},
journal = {Frontiers in Microbiology},
year = {2026},
month = oct,
doi = {10.3389/fmicb.2026.1984969},
url = {https://www.frontiersin.org/articles/10.3389/fmicb.2026.1984969/full},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - Enterovirus A71 neuroinvasion: central nervous system entry, blood–brain barrier dynamics, and multistage constraints
AU - Yi Zhang
AU - Zhi Li
AU - Yu Gu
AU - Bo Huang
AU - Zhenzhuang Zou
PY - 2026
DA - 2026/10/27
JO - Frontiers in Microbiology
DO - 10.3389/fmicb.2026.1984969
UR - https://www.frontiersin.org/articles/10.3389/fmicb.2026.1984969/full
AB - Enterovirus A71 (EV-A71) is an important cause of severe neurological complications of hand, foot, and mouth disease in children. Most infections remain confined to peripheral sites, whereas only a small proportion progress to central nervous system (CNS) disease, and the mechanisms underlying this transition remain incompletely understood. Here, we reappraise EV-A71 neuropathogenesis as a multistage process comprising peripheral replication, systemic dissemination, CNS entry, establishment of productive CNS infection, and subsequent tissue injury. This distinction is important because these events are mechanistically connected but not interchangeable. Current evidence supports both neurovascular and peripheral neural routes of CNS entry, although the nature and strength of the supporting evidence differ. Human-derived blood–brain barrier (BBB) models demonstrate that EV-A71 and virus-associated carriers can engage and cross neurovascular interfaces, whereas temporal studies in animals, perturbation of axonal transport, and compartmentalized neuronal models provide stronger causal support for retrograde axonal transport once the virus has accessed peripheral nerves. These findings establish mechanistic feasibility, but the timing, necessity, and relative contribution of each route during natural infection in children remain unresolved. We further emphasize that BBB crossing is not synonymous with BBB disruption, and that CNS entry does not necessarily result in productive CNS infection. On this basis, we propose a multistage progression-constraint model, in which progression to severe neurological disease requires EV-A71 to overcome distinct constraints imposed by tissue context, viral properties, and host factors at successive stages. This framework provides a testable explanation for why most infections remain peripheral while only a minority progress to severe neurological disease, and highlights the need for longitudinal clinical studies and directly comparable experimental models to identify where disease trajectories first diverge.
SN - 1664-302X
ER -